9,10-Dioxoanthracenyldithiocarbamates effectively inhibit the proliferation of non-small cell lung cancer by targeting multiple protein tyrosine kinases

Anthraquinones have attracted considerable interest in the realm of cancer treatment owing to their potent anticancer properties. This study evaluates the potential of a series of new anthraquinone derivatives as anticancer agents for non-small-cell lung cancer (NSCLC). The compounds were subjected...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mateusz Olszewski, Maryna Stasevych, Viktor Zvarych, Natalia Maciejewska
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2024-12-01
Col·lecció:	Journal of Enzyme Inhibition and Medicinal Chemistry
Matèries:	Anthraquinones DNA damage non-small-cell lung cancer protein tyrosine kinase
Accés en línia:	https://www.tandfonline.com/doi/10.1080/14756366.2023.2284113
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!